EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib. Basset J, Marchal L, Hovnanian A. J Invest Dermatol 2023;143:294-304.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Basset J, Marchal L, Hovnanian A. EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib. J Invest Dermatol 2023;143:294-304.
PMID: 36116508